Completed OBSERVATIONAL NCT01310309

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

EXecutive Registry: XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V® EECSS) in the Treatment of the Specific Setting of Patients With Multi-vessel Coronary Artery Disease.

Sponsor: Abbott Medical Devices

Conditions Coronary Artery Disease Coronary Artery Restenosis Coronary Artery Stenosis Coronary Disease

Interventions Coronary artery placement of a drug-eluting stent

Updated 9 times since 2017 Last updated: Dec 20, 2012 Started: Sep 30, 2007 Primary completion: Oct 31, 2010 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01310309, this observational or N/A phase trial focuses on Coronary Artery Disease and Coronary Artery Restenosis and remains completed. Sponsored by Abbott Medical Devices, it has been updated 9 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2018 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Dec 2018 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None
Feb 2017 — Apr 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices

Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Agrigento, Italy , Bologna, Italy , Catania, Italy , Catanzaro, Italy , Foggia, Italy , Genova, Italy , Mantova, Italy , Milan, Italy , Napoli, Italy , Roma, Italy and 6 more locations